Pharmaceuticals News

NEW YORK, Nov. 01, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced rotational changes and...

MALVERN, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...

Dyadic to Report Q3 2026 Financial Results and Host Conference Call on Thursday November 12, 2026

WOODCLIFF LAKE, N.J., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has adopted...

TME Pharma Publishes Its Semi Annual Results and Half-Year Report Berlin, Germany, October 30, 2026, 18:00 CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotech-company with clinical assets...

TME Pharma publie ses résultats semestriels et son rapport semestriel Berlin, Allemagne, le 30 octobre 2026, 18 h 00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), une société de...

The Phase III AIRWARD™ trial was published today on ClinicalTrials.gov (NCT07907991).1AIRWARD will evaluate the efficacy and safety of verducatib, an investigational oral therapy for COPD.1The Phase...

First FDA-approved biologic specifically designed to cross blood-brain barrier wins award dedicated to exceptional scientific leadership and transformational impact on patient careFirst new...

Kraig Labs (OTCQB: KBLB) shipped its spider silk super fibers to a company with experience developing materials alongside major aerospace manufacturers.

NeOnc (NASDAQ:NTHI) is building a powerful story and is advancing potential treatments for some of the most difficult-to-treat brain cancers